Fidelis Capital Partners’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$532K Buy
10,856
+382
+4% +$17.8K 0.04% 309
2025
Q4
$457K Buy
10,474
+39
+0.4% +$1.78K 0.03% 329
2025
Q3
$470K Buy
10,435
+45
+0.4% +$1.98K 0.04% 314
2025
Q2
$468K Buy
10,390
+32
+0.3% +$1.43K 0.04% 275
2025
Q1
$479K Buy
10,358
+1,163
+13% +$48.6K 0.05% 255
2024
Q4
$373K Buy
9,195
+3,794
+70% +$147K 0.04% 301
2024
Q3
$220K Buy
+5,401
New +$203K 0.03% 375

Other funds holding EXC

Fidelis Capital Partners's EXC Position: Q1 2026 in Review

Fidelis Capital Partners increased its Exelon (EXC) stake by 3.6% in Q1 2026, buying an estimated $17.8K and bringing the position to 10,856 shares worth $532K. The position accounts for 0.04% of the portfolio, ranked #309.

Fidelis Capital Partners first reported a position in EXC in Q3 2024 and has held it in 7 quarters since. 1,277 funds tracked by Wall St. Rank hold EXC as of Q1 2026.

  • Fidelis Capital Partners held 10,856 shares of Exelon worth $532K as of Q1 2026.
  • Fidelis Capital Partners bought 382 Exelon shares in Q1 2026, an estimated $17.8K.
  • Exelon made up 0.04% of Fidelis Capital Partners's portfolio in Q1 2026, its #309 holding.
  • Fidelis Capital Partners first reported a position in Exelon in Q3 2024 and has held it in 7 quarters since.
  • 1,277 funds tracked by Wall St. Rank held Exelon as of Q1 2026.

Based on Fidelis Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.